SCHEMBL24316209

SCHEMBL24316209

CC(C)NC1CCCCC1NCc1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.52
MAOB P27338 2/20 0.52
MAOA P21397 1/20 0.52
SSTR3 P32745 6/20 0.48
CARM1 Q86X55 2/20 0.46
PRMT6 Q96LA8 2/20 0.46
SLC6A2 P23975 2/20 0.45
SLC6A3 Q01959 2/20 0.45
HRH2 P25021 1/20 0.45
DRD3 P35462 1/20 0.45
KCNH2 Q12809 1/20 0.44
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.40
GRIA4 P48058 1/20 0.39
CCNT1 O60563 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26620816 0.86 KDM1A (0.55) KDM1AMAOBMAOASSTR3CARM1
SCHEMBL27010643 0.82 KDM1A (0.47) KDM1AMAOASSTR3L3MBTL1KDM4E
SCHEMBL20063373 0.82 KDM1A (0.47) KDM1AMAOASSTR3L3MBTL1KDM4E
SCHEMBL10882199 0.77 KCNH2 (0.61) KDM1AMAOBMAOACARM1PRMT6
SCHEMBL1041164 0.76 KCNH2 (0.60) KDM1AMAOBMAOACARM1PRMT6
SCHEMBL27010662 0.75 ALDH1A1 (0.61) KDM1AMAOBMAOAALDH1A1KDM4E
SCHEMBL2732150 0.74 CARM1 (0.63) KDM1AMAOBMAOACARM1PRMT6
SCHEMBL27010659 0.74 KDM1A (0.47) KDM1AMAOBMAOASSTR3L3MBTL1
Hydrochloric Acid SCHEMBL4879048 0.72 CARM1 (0.62) KDM1AMAOBMAOACARM1PRMT6
SCHEMBL30779531 0.72 TAAR1 (0.50) MAOBMAOAATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed